Altintas, E. Et Al. 2022. Evaluation of Serum Ischemia Modified Albumin in Patients With COVID-19 Pneumonia: A Case-Control Study.. Cureus , vol.14, no.8 .

Altintas, E., Sabirli, R., Yuksekkaya, E., Kurt, Ö., & Koseler, A., (2022). Evaluation of Serum Ischemia Modified Albumin in Patients With COVID-19 Pneumonia: A Case-Control Study.. Cureus , vol.14, no.8.

Altintas, Emel Et Al. "Evaluation of Serum Ischemia Modified Albumin in Patients With COVID-19 Pneumonia: A Case-Control Study.," Cureus , vol.14, no.8, 2022

Altintas, Emel Et Al. "Evaluation of Serum Ischemia Modified Albumin in Patients With COVID-19 Pneumonia: A Case-Control Study.." Cureus , vol.14, no.8, 2022

Altintas, E. Et Al. (2022) . "Evaluation of Serum Ischemia Modified Albumin in Patients With COVID-19 Pneumonia: A Case-Control Study.." Cureus , vol.14, no.8.

@article{article, author={Emel Altintas Et Al. }, title={Evaluation of Serum Ischemia Modified Albumin in Patients With COVID-19 Pneumonia: A Case-Control Study.}, journal={Cureus}, year=2022}